[The advantage of heterozygotes] - PubMed
[Article in Spanish]
- PMID: 15034964
Editorial
[The advantage of heterozygotes]
[Article in Spanish]
Basilio A Kotsias. Medicina (B Aires). 2004.
No abstract available
Comment in
-
Roncoroni AJ. Roncoroni AJ. Medicina (B Aires). 2004;64(3):282-3; author reply 283. Medicina (B Aires). 2004. PMID: 15239549 Spanish. No abstract available.
Similar articles
-
Derichs N, Schuster A, Grund I, Ernsting A, Stolpe C, Körtge-Jung S, Gallati S, Stuhrmann M, Kozlowski P, Ballmann M. Derichs N, et al. Clin Genet. 2005 Jun;67(6):529-31. doi: 10.1111/j.1399-0004.2005.00437.x. Clin Genet. 2005. PMID: 15857421 No abstract available.
-
Cystic fibrosis heterozygotes do not have increased platelet activation.
Tarnow I, Michelson AD, Frelinger AL 3rd, Linden MD, Li Y, Fox ML, Barnard MR, O'Sullivan BP. Tarnow I, et al. Thromb Res. 2007;121(2):159-62. doi: 10.1016/j.thromres.2007.04.004. Epub 2007 May 29. Thromb Res. 2007. PMID: 17532368
-
Bienvenu T, Bousquet S, Souville I, Beldjord C. Bienvenu T, et al. Ann Biol Clin (Paris). 1999 Nov-Dec;57(6):741-2. Ann Biol Clin (Paris). 1999. PMID: 10572229 French. No abstract available.
-
[Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
Romey MC. Romey MC. Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):429-37. Ann Biol Clin (Paris). 2006. PMID: 17040873 Review. French.
-
[Modifier genes and cystic fibrosis].
Corvol H, Flamant C, Vallet C, Clement A, Brouard J. Corvol H, et al. Arch Pediatr. 2006 Jan;13(1):57-63. doi: 10.1016/j.arcped.2005.09.029. Epub 2005 Nov 7. Arch Pediatr. 2006. PMID: 16274977 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical